Responses
Clinical Trials Monitor
Re-induction using whole cell melanoma vaccine genetically modified to melanoma stem cells-like beyond recurrence extends long term survival of high risk resected patients - updated results
Compose a Response to This Article
Other responses
No responses have been published for this article.
